Not applicableEnded earlyNCT00578461What this trial is testingT-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINEWho this might be right forLeukemiaCancerLymphoma+2 more Baylor College of Medicine 26
Testing effectiveness (Phase 2)UnknownNCT05066958What this trial is testingEx-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCTWho this might be right forAcute Myeloid LeukemiaHigh Risk Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia, in Relapse+4 more Federal Research Institute of Pediatric Hematology, Oncology and Immunology 20
Not applicableStudy completedNCT02652715What this trial is testingSalvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-Cell LymphomaAdult T-Cell Leukemia/LymphomaAnaplastic Large Cell Lymphoma+29 more Mayo Clinic 29
Early research (Phase 1)Study completedNCT00348985What this trial is testingPXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or LymphomasWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+58 more National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT03301168What this trial is testingStudy of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell TransplantWho this might be right forAcute Lymphoblastic LeukemiaLeukemia, Acute Myeloid (AML), ChildLymphoma, Non-Hodgkin+6 more Bellicum Pharmaceuticals 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05434689What this trial is testingCOMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomideWho this might be right forMultiple Myeloma University of Alabama at Birmingham 80
Early research (Phase 1)Study completedNCT01748721What this trial is testingMORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+43 more Morphotek 27
Not applicableStudy completedNCT00964821What this trial is testingFlu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell TransplantWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more City of Hope Medical Center 459
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07573436What this trial is testingLoncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)Who this might be right forPost-transplant Lymphoproliferative Disorder University of Utah 23
Testing effectiveness (Phase 2)Study completedNCT02086552What this trial is testingSonidegib and Lenalidomide After Stem Cell Transplant in Treating Patients With Multiple MyelomaWho this might be right forRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma Mayo Clinic 28
Not applicableStudy completedNCT00376922What this trial is testingMusic in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+7 more Wake Forest University Health Sciences 65
Testing effectiveness (Phase 2)WithdrawnNCT03086395What this trial is testingSingle Agent Obinutuzumab in Relapsed/Refractory Post-Transplant Lymphoproliferative Disorder (PTLD)Who this might be right forPost-transplant Lymphoproliferative DisorderPTLD Case Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT04473911What this trial is testingHaplo Peripheral Blood Sct In GVHD PreventionWho this might be right forGVHDAMLALL+13 more Zachariah Michael DeFilipp 25
Large-scale testing (Phase 3)Looking for participantsNCT07413809What this trial is testingPrevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing RegimenWho this might be right forMultiple Myeloma The Affiliated People's Hospital of Ningbo University 92
Testing effectiveness (Phase 2)Ended earlyNCT01419795What this trial is testingLenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell TransplantWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more Fred Hutchinson Cancer Center 3
Large-scale testing (Phase 3)Study completedNCT05663827What this trial is testingRuxolitinib as add-on Therapy in Steroid-refractory Graft-vs-host DiseaseWho this might be right forSteroid Refractory GVHD Yi-Lun Wang 6
Testing effectiveness (Phase 2)Ended earlyNCT02353468What this trial is testingBortezomib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Undergoing Stem Cell TransplantWho this might be right forRefractory Plasma Cell Myeloma University of Colorado, Denver 3
Testing effectiveness (Phase 2)Looking for participantsNCT05786040What this trial is testingTafasitamab and Rituximab for Front-Line Treatment of Post-Transplant Lymphoproliferative DisorderWho this might be right forMonomorphic B-Cell Post-Transplant Lymphoproliferative DisorderPolymorphic Post-Transplant Lymphoproliferative Disorder Timothy Voorhees 28
Early research (Phase 1)Study completedNCT01330173What this trial is testingVismodegib After Stem Cell Transplant in Treating Patients With High-Risk First Remission or Relapsed Multiple MyelomaWho this might be right forDS Stage I Plasma Cell MyelomaDS Stage II Plasma Cell MyelomaDS Stage III Plasma Cell Myeloma+1 more National Cancer Institute (NCI) 50
Large-scale testing (Phase 3)Study completedNCT01295710What this trial is testingStudy of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)Who this might be right forGVHDAdult Acute Myeloid LeukemiaAdult Acute Lymphoid Leukemia+1 more Neovii Biotech 260